Multicompartmental Analysis of [11C]-Carfentanil Binding to Opiate Receptors in Humans Measured by Positron Emission Tomography
暂无分享,去创建一个
H. N. Wagner | H. Mayberg | J. Links | A. Wilson | R. Dannals | H. Ravert | H. Wagner | J. Frost | K. Douglass | H. S. Mayberg | R. F. Dannals | J. J. Frost | K. H. Douglass | J. M. Links | A. A. Wilson | H. T. Ravert | William C. Crozier | W. C. Crozier
[1] M E Phelps,et al. Performance evaluation of a positron tomograph designed for brain imaging. , 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[2] E. J. Simon,et al. Selective changes in mu, delta and kappa opioid receptor binding in certain limbic regions of the brain in Alzheimer's disease patients. , 1987, Brain research.
[3] E. J. Simon,et al. Selective changes in μ, δ and ϰ opioid receptor binding in certain limbic regions of the brain in Alzheimer's disease patients , 1987, Brain Research.
[4] M. Kuhar,et al. Distribution and physiological significance of opioid receptors in the brain. , 1983, British medical bulletin.
[5] L. Eriksson,et al. Imaging of [11C]-labelled Ro 15-1788 binding to benzodiazepine receptors in the human brain by positron emission tomography. , 1985, Journal of psychiatric research.
[6] M. Reivich,et al. THE [14C]DEOXYGLUCOSE METHOD FOR THE MEASUREMENT OF LOCAL CEREBRAL GLUCOSE UTILIZATION: THEORY, PROCEDURE, AND NORMAL VALUES IN THE CONSCIOUS AND ANESTHETIZED ALBINO RAT 1 , 1977, Journal of neurochemistry.
[7] C. D. Arnett,et al. Serial [18F]N-methylspiroperidol PET studies to measure changes in antipsychotic drug D-2 receptor occupancy in schizophrenic patients , 1988, Biological Psychiatry.
[8] A. Herz,et al. Opiate receptor binding sites in human brain , 1982, Brain Research.
[9] J. Frost. Imaging neuronal biochemistry by emission computed tomography: focus on neuroreceptors , 1986 .
[10] S H Snyder,et al. The opiate receptor. , 1975, Neurosciences Research Program bulletin.
[11] G. Sedvall,et al. Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET. , 1986, Science.
[12] J. Baron,et al. In vivo quantitative imaging of dopamine receptors in human brain using positron emission tomography and [76Br]bromospiperone. , 1985, European journal of pharmacology.
[13] A. Gjedde,et al. Quantification of Neuroreceptors in the Living Human Brain. I. Irreversible Binding of Ligands , 1986, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[14] J S Fowler,et al. Kinetic Modeling of Receptor‐Ligand Binding Applied to Positron Emission Tomographic Studies with Neuroleptic Tracers , 1987, Journal of neurochemistry.
[15] L. Iversen,et al. Opiate and neuroleptic receptor alterations in human schizophrenic brain tissue. , 1980, Advances in biochemical psychopharmacology.
[16] K A Frey,et al. Quantitative in vivo receptor binding III: Tracer kinetic modeling of muscarinic cholinergic receptor binding. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[17] Dean F. Wong,et al. Imaging Opiate Receptors in the Human Brain by Positron Tomography , 1985, Journal of computer assisted tomography.
[18] C. Pert,et al. In vivo autoradiography: Visualization of stress-induced changes in opiate receptor occupancy in the rat brain , 1984, Brain Research.
[19] C. Patlak,et al. Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data. Generalizations , 1985, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[20] E. H. Twizell. The mathematical modeling of metabolic and endocrine systems: E.R. Carson, C. Cobelli and L. Finkelstein John Wiley and Sons, Chichester, Sussex, UK, 394 pp., £45.15, 1983 , 1984 .
[21] K. B. Larson,et al. Strategies for in vivo Measurement of Receptor Binding Using Positron Emission Tomography , 1986, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[22] S. Snyder,et al. Imaging benzodiazepine receptors in man with [11C]suriclone by positron emission tomography. , 1986, European journal of pharmacology.
[23] Jonathan M. Links,et al. Imaging dopamine receptors in the human brain by positron tomography , 1983 .
[24] J M Links,et al. Quantification of Neuroreceptors in the Living Human Brain. II. Inhibition Studies of Receptor Density and Affinity , 1986, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[25] H. Frenk. Pro- and anticonvulsant actions of morphine and the endogenous opioids: Involvement and interactions of multiple opiate and non-opiate systems , 1983, Brain Research Reviews.
[26] B. Zeeberg,et al. Quantification of Human Caudate D2 Dopamine Receptor Density with Positron Emission Tomography: A Review of the Model , 1987, IEEE Transactions on Medical Imaging.
[27] M. Mintun,et al. A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography , 1984, Annals of neurology.
[28] E. Hoffman,et al. Quantitation in Positron Emission Computed Tomography: 1. Effect of Object Size , 1979, Journal of computer assisted tomography.
[29] Alan A. Wilson,et al. Mu‐opiate receptors measured by positron emission tomography are increased in temporal lobe epilepsy , 1988, Annals of neurology.
[30] Henry N. Wagner,et al. Kinetics of binding to opiate receptors in vivo predicted from in vitro parameters , 1984, Brain Research.
[31] Albert Gjedde,et al. Calculation of cerebral glucose phosphorylation from brain uptake of glucose analogs in vivo: A re-examination , 1982, Brain Research Reviews.
[32] J. Links,et al. Imaging dopamine receptors in the human brain by positron tomography. , 1984, Science.